The University of Ibadan is a public research university in Ibadan, Nigeria. The university was founded in 1948 as University College Ibadan, one of many colleges within the University of London. It became an independent university in 1962 and is the oldest degree-awarding institution in Nigeria.

During the past decade, University of Ibadan conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Ibadan" #1 sponsor was "George Washington University" with 1 trials, followed by "National Human Genome Research Institute (NHGRI)" with 1 trials sponsored, "Northwestern University" with 1 trials sponsored, "University of Chicago" with 1 trials sponsored and "University of Chile" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Ibadan" #1 collaborator was "University of Ibadan" with 2 trials as a collaborator, "Breast Cancer Research Foundation" with 1 trials as a collaborator, "Columbia University" with 1 trials as a collaborator, "Duke University" with 1 trials as a collaborator and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "University of Ibadan" are "Depression" (2 trials), "Adolescent HIV Infection" (1 trials), "Anxiety" (1 trials), "Breast Cancer" (1 trials) and "Covid-19" (1 trials). Many other conditions were trialed in "University of Ibadan" in a lesser frequency.

Most popular intervention types in "University of Ibadan" are "Other" (3 trials), "Behavioral" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Capecitabine" (1 trials), "Egg demand creation campaign" (1 trials), "Exposure to the SARS-CoV-2 and its consequences" (1 trials), "Peer navigation" (1 trials) and "Retinol Isotope Dilution (RID)" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Ibadan" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of Ibadan". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in University of Ibadan, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Ibadan, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".